{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:11:31Z","timestamp":1761894691285},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s11894-008-0019-6","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T12:15:52Z","timestamp":1205756152000},"page":"39-46","source":"Crossref","is-referenced-by-count":5,"title":["Alcoholic steatohepatitis: Management and prognosis"],"prefix":"10.1007","volume":"9","author":[{"given":"Jacquelyn J.","family":"Maher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,18]]},"reference":[{"key":"19_CR1","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","volume":"110","author":"P. Mathurin","year":"1996","unstructured":"Mathurin P, Duchatelle V, Ramond MJ, et al.: Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996, 110:1847\u20131853.","journal-title":"Gastroenterology"},{"key":"19_CR2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","volume":"326","author":"M.J. Ramond","year":"1992","unstructured":"Ramond MJ, Poynard T, Rueff B, et al.: A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992, 326:507\u2013512.","journal-title":"N Engl J Med"},{"key":"19_CR3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jhep.2006.02.010","volume":"44","author":"D. Thabut","year":"2006","unstructured":"Thabut D, Naveau S, Charlotte F, et al.: The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease. J Hepatol 2006, 44:1175\u20131185.","journal-title":"J Hepatol"},{"key":"19_CR4","first-page":"1029","volume":"81","author":"S. Goldberg","year":"1986","unstructured":"Goldberg S, Mendenhall C, Anderson S, et al.: VA Cooperative Study on Alcoholic Hepatitis. IV. The significance of clinically mild alcoholic hepatitis\u2014describing the population with minimal hyperbilirubinemia. Am J Gastroenterol 1986, 81:1029\u20131034.","journal-title":"Am J Gastroenterol"},{"key":"19_CR5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","volume":"75","author":"W.C. Maddrey","year":"1978","unstructured":"Maddrey WC, Boitnott JK, Bedine MS, et al.: Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978, 75:193\u2013199.","journal-title":"Gastroenterology"},{"key":"19_CR6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","volume":"110","author":"R.L. Carithers Jr","year":"1989","unstructured":"Carithers RL Jr, Herlong HF, Diehl AM, et al.: Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial [see comments]. Ann Intern Med 1989, 110:685\u2013690.","journal-title":"Ann Intern Med"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"E. Akriviadis","year":"2000","unstructured":"Akriviadis E, Botla R, Briggs W, et al.: Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:1637\u20131648.","journal-title":"Gastroenterology"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","volume":"54","author":"E.H. Forrest","year":"2005","unstructured":"Forrest EH, Evans CD, Stewart S, et al.: Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow Alcoholic Hepatitis Score. Gut 2005, 54:1174\u20131179.","journal-title":"Gut"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","volume":"41","author":"W. Dunn","year":"2005","unstructured":"Dunn W, Jamil LH, Brown LS, et al.: MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005, 41:353\u2013358.","journal-title":"Hepatology"},{"key":"19_CR10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","volume":"38","author":"K. Kulkarni","year":"2004","unstructured":"Kulkarni K, Tran T, Medrano M, et al.: The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. J Clin Gastroenterol 2004, 38:453\u2013459.","journal-title":"J Clin Gastroenterol"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-2-2","volume":"2","author":"M. Sheth","year":"2002","unstructured":"Sheth M, Riggs M, Patel T: Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002, 2:2.","journal-title":"BMC Gastroenterol"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","volume":"42","author":"W. Srikureja","year":"2005","unstructured":"Srikureja W, Kyulo NL, Runyon BA, Hu KQ: MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 2005, 42:700\u2013706.","journal-title":"J Hepatol"},{"key":"19_CR13","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","volume":"311","author":"C.L. Mendenhall","year":"1984","unstructured":"Mendenhall CL, Anderson S, Garcia-Pont P, et al.: Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984, 311:1464\u20131470.","journal-title":"N Engl J Med"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","volume":"36","author":"P. Mathurin","year":"2002","unstructured":"Mathurin P, Mendenhall CL, Carithers RL, Jr., et al.: Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002, 36:480\u2013487.","journal-title":"J Hepatol"},{"key":"19_CR15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","volume":"37","author":"E. Christensen","year":"1995","unstructured":"Christensen E, Gluud C: Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables [see comments]. Gut 1995, 37:113\u2013118.","journal-title":"Gut"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","volume":"113","author":"T.F. Imperiale","year":"1990","unstructured":"Imperiale TF, McCullough AJ: Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med 1990, 113:299\u2013307.","journal-title":"Ann Intern Med"},{"key":"19_CR17","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1572-0241.1998.00587.x","volume":"93","author":"A.J. McCullough","year":"1998","unstructured":"McCullough AJ, O\u2019Connor JF: Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998, 93:2022\u20132036.","journal-title":"Am J Gastroenterol"},{"key":"19_CR18","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1053\/jlts.2003.50245","volume":"9","author":"M. Charlton","year":"2003","unstructured":"Charlton M: Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence. Liver Transpl 2003, 9:S58\u2013S62.","journal-title":"Liver Transpl"},{"key":"19_CR19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0192-0561(99)00005-3","volume":"21","author":"N. Magy","year":"1999","unstructured":"Magy N, Cribier B, Schmitt C, et al.: Effects of corticosteroids on HCV infection. Int J Immunopharmacol 1999, 21:253\u2013261.","journal-title":"Int J Immunopharmacol"},{"key":"19_CR20","doi-asserted-by":"crossref","unstructured":"McClain C, Barve S, Joshi-Barve S, et al.: Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease. Alcohol Clin Exp Res 2005, 29:180S\u2013188S.","DOI":"10.1097\/01.alc.0000189276.34230.f5"},{"key":"19_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003495-199039020-00001","volume":"39","author":"A.M. Ehrly","year":"1990","unstructured":"Ehrly AM: Drugs that alter blood viscosity. Their role in therapy. Drugs 1990, 39:155\u2013159.","journal-title":"Drugs"},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1530-0277.1995.tb01560.x","volume":"19","author":"C. Mendenhall","year":"1995","unstructured":"Mendenhall C, Roselle GA, Gartside P, Moritz T: Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcohol Clin Exp Res 1995, 19:635\u2013641.","journal-title":"Alcohol Clin Exp Res"},{"key":"19_CR23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clnu.2006.01.018","volume":"25","author":"M. Plauth","year":"2006","unstructured":"Plauth M, Cabre E, Riggio O, et al.: ESPEN Guidelines on enteral nutrition: Liver disease. Clin Nutr 2006, 25:285\u2013294.","journal-title":"Clin Nutr"},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/00042737-200412000-00023","volume":"16","author":"M.A. Alvarez","year":"2004","unstructured":"Alvarez MA, Cabre E, Lorenzo-Zuniga V, et al.: Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study. Eur J Gastroenterol Hepatol 2004, 16:1375\u20131380.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"19_CR25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","volume":"32","author":"E. Cabre","year":"2000","unstructured":"Cabre E, Rodriguez-Iglesias P, Caballeria J, et al.: Short-and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000, 32:36\u201342.","journal-title":"Hepatology"},{"key":"19_CR26","first-page":"G467","volume":"278","author":"H. Kono","year":"2000","unstructured":"Kono H, Enomoto N, Connor HD, et al.: Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. Am J Physiol 2000, 278:G467\u2013G476.","journal-title":"Am J Physiol"},{"key":"19_CR27","first-page":"1694","volume":"277","author":"A.A. Nanji","year":"1996","unstructured":"Nanji AA, Yang EK, Fogt F, et al.: Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol Exp Ther 1996, 277:1694\u20131700.","journal-title":"J Pharmacol Exp Ther"},{"key":"19_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","volume":"99","author":"K.V. Menon","year":"2004","unstructured":"Menon KV, Stadheim L, Kamath PS, et al.: A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol 2004, 99:255\u2013260.","journal-title":"Am J Gastroenterol"},{"key":"19_CR29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","volume":"37","author":"L. Spahr","year":"2002","unstructured":"Spahr L, Rubbia-Brandt L, Frossard JL, et al.: Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol 2002, 37:448\u2013455.","journal-title":"J Hepatol"},{"key":"19_CR30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","volume":"38","author":"H. Tilg","year":"2003","unstructured":"Tilg H, Jalan R, Kaser A, et al.: Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 2003, 38:419\u2013425.","journal-title":"J Hepatol"},{"key":"19_CR31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","volume":"39","author":"S. Naveau","year":"2004","unstructured":"Naveau S, Chollet-Martin S, Dharancy S, et al.: A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004, 39:1390\u20131397.","journal-title":"Hepatology"},{"key":"19_CR32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2005.06.003","volume":"43","author":"P. Mathurin","year":"2005","unstructured":"Mathurin P: Corticosteroids for alcoholic hepatitis\u2014what\u2019s next? J Hepatol 2005, 43:526\u2013533.","journal-title":"J Hepatol"},{"key":"19_CR33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","volume":"44","author":"M. Phillips","year":"2006","unstructured":"Phillips M, Curtis H, Portmann B, et al.: Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis\u2014a randomised clinical trial. J Hepatol 2006, 44:784\u2013790.","journal-title":"J Hepatol"},{"key":"19_CR34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","volume":"40","author":"E. Mezey","year":"2004","unstructured":"Mezey E, Potter JJ, Rennie-Tankersley L, et al.: A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol 2004, 40:40\u201346.","journal-title":"J Hepatol"},{"key":"19_CR35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(02)00334-3","volume":"38","author":"R. Jalan","year":"2003","unstructured":"Jalan R, Sen S, Steiner C, et al.: Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003, 38:24\u201331.","journal-title":"J Hepatol"},{"key":"19_CR36","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/cc4985","volume":"10","author":"W. Laleman","year":"2006","unstructured":"Laleman W, Wilmer A, Evenepoel P, et al.: Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006, 10:R108.","journal-title":"Crit Care"},{"key":"19_CR37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2005.01.032","volume":"43","author":"S. Sen","year":"2005","unstructured":"Sen S, Mookerjee RP, Cheshire LM, et al.: Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. J Hepatol 2005, 43:142\u2013148.","journal-title":"J Hepatol"},{"key":"19_CR38","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s10620-006-9099-z","volume":"51","author":"S. Verma","year":"2006","unstructured":"Verma S, Ajudia K, Mendler M, Redeker A: Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events. Dig Dis Sci 2006, 51:1637\u20131643.","journal-title":"Dig Dis Sci"},{"key":"19_CR39","first-page":"210","volume":"86","author":"A. Chedid","year":"1991","unstructured":"Chedid A, Mendenhall CL, Gartside P, et al.: Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol 1991, 86:210\u2013216.","journal-title":"Am J Gastroenterol"},{"key":"19_CR40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0016-5085(87)90861-4","volume":"92","author":"H. Orrego","year":"1987","unstructured":"Orrego H, Blake JE, Blendis LM, Medline A: Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 1987, 92:208\u2013214.","journal-title":"Gastroenterology"},{"key":"19_CR41","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","volume":"38","author":"P. Mathurin","year":"2003","unstructured":"Mathurin P, Abdelnour M, Ramond MJ, et al.: Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 2003, 38:1363\u20131369.","journal-title":"Hepatology"},{"key":"19_CR42","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00042737-200507000-00011","volume":"17","author":"J.M. Morris","year":"2005","unstructured":"Morris JM, Forrest EH: Bilirubin response to corticosteroids in severe alcoholic hepatitis. Eur J Gastroenterol Hepatol 2005, 17:759\u2013762.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"19_CR43","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","volume":"30","author":"J.M. Mato","year":"1999","unstructured":"Mato JM, Camara J, Fernandez de Paz J, et al.: S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999, 30:1081\u20131089.","journal-title":"J Hepatol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-008-0019-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0019-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:04:01Z","timestamp":1559419441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-008-0019-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1007\/s11894-008-0019-6","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}